Similar articles

• Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues.

  Dawdy P. Dawdy P. J Clin Psychopharmacol. 2008 Jun;28(3):367-8; author reply 368. doi: 10.1097/JCP.0b013e318162a2df. J Clin Psychopharmacol. 2008. PMID: 18480707 No abstract available.
• Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

  Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group. Thase ME, et al. J Clin Psychopharmacol. 2006 Dec;26(6):600-9. doi: 10.1097/01.jcp.0000248603.76231.b7. J Clin Psychopharmacol. 2006. PMID: 17110817 Clinical Trial.
• Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.

  Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M. Endicott J, et al. J Affect Disord. 2008 Dec;111(2-3):306-19. doi: 10.1016/j.jad.2008.06.019. Epub 2008 Sep 5. J Affect Disord. 2008. PMID: 18774180 Clinical Trial.
• Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.

  Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valentí M, Vieta E. Cruz N, et al. Int J Neuropsychopharmacol. 2010 Feb;13(1):5-14. doi: 10.1017/S1461145709990344. Epub 2009 Jul 29. Int J Neuropsychopharmacol. 2010. PMID: 19638254 Review.
• Clinical highlights in bipolar depression: focus on atypical antipsychotics.

  Calabrese JR, Elhaj O, Gajwani P, Gao K. Calabrese JR, et al. J Clin Psychiatry. 2005;66 Suppl 5:26-33. J Clin Psychiatry. 2005. PMID: 16038599 Review.